PortfoliosLab logo
PortfoliosLab logo
Tools
Performance Analysis
Portfolio Analysis
Factor Model
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
PRCT vs. FSLEX
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility

Correlation

The correlation between PRCT and FSLEX is 0.35, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.


-0.50.00.51.00.4

Performance

PRCT vs. FSLEX - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in PROCEPT BioRobotics Corporation (PRCT) and Fidelity Environment and Alternative Energy Fund (FSLEX). The values are adjusted to include any dividend payments, if applicable.

0.00%10.00%20.00%30.00%40.00%50.00%60.00%70.00%SeptemberOctoberNovemberDecember2025February
19.18%
16.06%
PRCT
FSLEX

Key characteristics

Sharpe Ratio

PRCT:

0.82

FSLEX:

1.29

Sortino Ratio

PRCT:

1.91

FSLEX:

1.76

Omega Ratio

PRCT:

1.22

FSLEX:

1.23

Calmar Ratio

PRCT:

1.64

FSLEX:

1.42

Martin Ratio

PRCT:

4.76

FSLEX:

7.96

Ulcer Index

PRCT:

10.71%

FSLEX:

2.82%

Daily Std Dev

PRCT:

62.36%

FSLEX:

17.34%

Max Drawdown

PRCT:

-63.51%

FSLEX:

-50.21%

Current Drawdown

PRCT:

-28.01%

FSLEX:

-3.67%

Returns By Period

In the year-to-date period, PRCT achieves a -11.09% return, which is significantly lower than FSLEX's 2.49% return.


PRCT

YTD

-11.09%

1M

-15.08%

6M

18.17%

1Y

48.47%

5Y*

N/A

10Y*

N/A

FSLEX

YTD

2.49%

1M

-0.05%

6M

16.06%

1Y

22.66%

5Y*

9.46%

10Y*

8.12%

*Annualized

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Risk-Adjusted Performance

PRCT vs. FSLEX — Risk-Adjusted Performance Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

PRCT
The Risk-Adjusted Performance Rank of PRCT is 7979
Overall Rank
The Sharpe Ratio Rank of PRCT is 7474
Sharpe Ratio Rank
The Sortino Ratio Rank of PRCT is 7979
Sortino Ratio Rank
The Omega Ratio Rank of PRCT is 7474
Omega Ratio Rank
The Calmar Ratio Rank of PRCT is 8787
Calmar Ratio Rank
The Martin Ratio Rank of PRCT is 8080
Martin Ratio Rank

FSLEX
The Risk-Adjusted Performance Rank of FSLEX is 7171
Overall Rank
The Sharpe Ratio Rank of FSLEX is 6767
Sharpe Ratio Rank
The Sortino Ratio Rank of FSLEX is 6666
Sortino Ratio Rank
The Omega Ratio Rank of FSLEX is 6565
Omega Ratio Rank
The Calmar Ratio Rank of FSLEX is 7676
Calmar Ratio Rank
The Martin Ratio Rank of FSLEX is 8181
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

PRCT vs. FSLEX - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for PROCEPT BioRobotics Corporation (PRCT) and Fidelity Environment and Alternative Energy Fund (FSLEX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


Sharpe ratio
The chart of Sharpe ratio for PRCT, currently valued at 0.79, compared to the broader market-2.000.002.004.000.791.29
The chart of Sortino ratio for PRCT, currently valued at 1.87, compared to the broader market-4.00-2.000.002.004.006.001.871.76
The chart of Omega ratio for PRCT, currently valued at 1.21, compared to the broader market0.501.001.502.001.211.23
The chart of Calmar ratio for PRCT, currently valued at 1.58, compared to the broader market0.002.004.006.001.581.42
The chart of Martin ratio for PRCT, currently valued at 4.55, compared to the broader market-10.000.0010.0020.0030.004.557.96
PRCT
FSLEX

The current PRCT Sharpe Ratio is 0.82, which is lower than the FSLEX Sharpe Ratio of 1.29. The chart below compares the historical Sharpe Ratios of PRCT and FSLEX, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Rolling 12-month Sharpe Ratio1.002.003.004.00SeptemberOctoberNovemberDecember2025February
0.79
1.29
PRCT
FSLEX

Dividends

PRCT vs. FSLEX - Dividend Comparison

PRCT has not paid dividends to shareholders, while FSLEX's dividend yield for the trailing twelve months is around 0.40%.


TTM20242023202220212020201920182017201620152014
PRCT
PROCEPT BioRobotics Corporation
0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
FSLEX
Fidelity Environment and Alternative Energy Fund
0.40%0.41%0.39%0.69%0.28%0.87%0.86%1.00%0.83%0.71%3.70%14.89%

Drawdowns

PRCT vs. FSLEX - Drawdown Comparison

The maximum PRCT drawdown since its inception was -63.51%, which is greater than FSLEX's maximum drawdown of -50.21%. Use the drawdown chart below to compare losses from any high point for PRCT and FSLEX. For additional features, visit the drawdowns tool.


-35.00%-30.00%-25.00%-20.00%-15.00%-10.00%-5.00%0.00%SeptemberOctoberNovemberDecember2025February
-28.01%
-3.67%
PRCT
FSLEX

Volatility

PRCT vs. FSLEX - Volatility Comparison

PROCEPT BioRobotics Corporation (PRCT) has a higher volatility of 14.47% compared to Fidelity Environment and Alternative Energy Fund (FSLEX) at 5.94%. This indicates that PRCT's price experiences larger fluctuations and is considered to be riskier than FSLEX based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


0.00%5.00%10.00%15.00%20.00%25.00%30.00%35.00%SeptemberOctoberNovemberDecember2025February
14.47%
5.94%
PRCT
FSLEX
PortfoliosLab logo
Performance Analysis
Portfolio AnalysisPortfolio PerformanceStock ComparisonSharpe RatioMartin RatioTreynor RatioSortino RatioOmega RatioCalmar RatioSummers Ratio
Community
Discussions


Disclaimer

The information contained herein does not constitute investment advice and made available for educational purposes only. Prices and returns on equities are listed without consideration of fees, commissions, taxes, penalties, or interest payable due to purchasing, holding, or selling.

Copyright © 2025 PortfoliosLab